In a filing, Ionis Pharmaceuticals Inc revealed its EVP, Chief Business Officer Baroldi Joseph unloaded Company’s shares for reported $0.17 million on Apr 16 ’24. In the deal valued at $41.60 per share,4,006 shares were sold. As a result of this transaction, Baroldi Joseph now holds 19,631 shares worth roughly $0.81 million.
Then, Birchler Brian sold 905 shares, generating $37,698 in total proceeds. Upon selling the shares at $41.66, the EVP, Corp and Development Ops now owns 46,156 shares.
Before that, Monia Brett P sold 387 shares. Ionis Pharmaceuticals Inc shares valued at $17,219 were divested by the Chief Executive Officer at a price of $44.49 per share. As a result of the transaction, Monia Brett P now holds 173,751 shares, worth roughly $7.14 million.
Wolfe Research upgraded its Ionis Pharmaceuticals Inc [IONS] rating to an Outperform from a a Peer perform in a research note published recently. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in early January from “a Neutral” to “a Buy”. BofA Securities also remained covering IONS and has increased its forecast on October 23, 2023 with a “Neutral” recommendation from previously “an Underperform” rating. Raymond James started covering the stock on September 29, 2023. It rated IONS as “a Strong buy”.
Price Performance Review of IONS
On Monday, Ionis Pharmaceuticals Inc [NASDAQ:IONS] saw its stock jump 0.96% to $41.07. Over the last five days, the stock has lost -1.16%. Ionis Pharmaceuticals Inc shares have fallen nearly -18.82% since the year began. Nevertheless, the stocks have risen 13.67% over the past one year. While a 52-week high of $54.44 was reached on 01/12/24, a 52-week low of $34.32 was recorded on 04/19/24. SMA at 50 days reached $43.95, while 200 days put it at $45.37. A total of 0.67 million shares were traded, compared to the trading of 0.85 million shares in the previous session.
Levels Of Support And Resistance For IONS Stock
The 24-hour chart illustrates a support level at 40.49, which if violated will result in even more drops to 39.90. On the upside, there is a resistance level at 41.74. A further resistance level may holdings at 42.41. The Relative Strength Index (RSI) on the 14-day chart is 37.41, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.41%. Stochastics %K at 9.37% indicates the stock is a buying.
